Forte Biosciences (FBRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Policy economists average 35.1 staff across 34 participating central banks. The range is zero to 160 persons. Among the same ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback